Radiofrequency technology treatment can clear brain toxins while awake

A new paper has presented clinical studies that show how treating the brain while it is awake with radiofrequency wave treatment can induce brain cleansing that is normally achieved with sleep.

The bioengineered radiofrequency technology has the potential to counter the effects of insomnia and sleep deprivation on brain toxin cleansing, and to reduce the amount of sleep normally required for brain toxin cleansing.

“An ability to safely induce brain cleansing during wakefulness is important because of the reduced sleep and sleep disturbances that occur during ageing and in multiple brain disorders of ageing such as Alzheimer’s Disease and Parkinson’s Disease,” said Dr. Gary Arendash, author of the paper and principal at RF Longevity.

In clinical studies performed at the University of South Florida, Alzheimer’s patients were given daily radiofrequency wave treatment during wakefulness at home by their caregivers. Both blood and brain levels of the toxins beta-amyloid and tau were measured at several months and one to two years into treatment.

Radiofrequency wave treatment resulted in a substantial increase in toxin drainage from the brain and into blood of the Alzheimer’s patients.

“It appears that radiofrequency wave treatment increases the natural flow of fluid out of the brain through meningeal lymphatic vessels” explained Dr. Arendash.

“Acting as sinks, these lymphatic vessels normally carry around 50 per cent of toxins and metabolic wastes out of the brain during sleep, but their flow is decreased in normal aging and Alzheimer’s Disease.”

Lack of sleep and sleep disturbances contribute to accumulation of the toxins beta-amyloid and tau in the brain, leading to Alzheimer’s Disease. In the treated Alzheimer’s patients, cognitive impairment was stopped and even reversed by one-hour radiofrequency wave treatments to the entire brain during wakefulness.

“We are excited by the implications of these clinical findings, which appear to be the first to provide biomarker evidence of increased brain cleansing by any human clinical intervention” said Dr. Arendash.

He emphasised the importance of additional clinical trials with this bioengineered technology in both normal humans and those with neurologic disorders of ageing to determine the technology’s full potential for human brain cleansing.